Amid massive changes in economic and immigration policy nationwide, Docket Alarm data reveals that bankruptcy filings have grown steadily nationwide in the first half of 2025, compared to the first ...

As the Trump Administration moves rapidly to install artificial intelligence throughout the federal government, a growing number of journalists, non-profits, lawyers, and executives are filing Freedom ...

It’s safe to say that the federal government faces a massive amount of litigation. It is the nation’s largest employer, employing approximately 3 million Americans, more than megacorporations like ...

From demands for details on Federal Reserve salaries to inquiries into Treasury’s handling of sanctions, ethics issues, and the idea of a U.S. sovereign wealth fund, the FOIA requests show where ...

While Roblox remains in the spotlight for these allegations, the company is also bringing lawsuits of its own. This year, the company has filed six trademark suits. Some of these lawsuits are against ...

As biotech firm Sarepta Therapeutics (NASD: SRPT) battles patient deaths, regulatory action, and a cratering stock price, its dealings with the Food and Drug Administration are being monitored closely ...

As the Trump Administration’s tariff pause is set to expire next week, SunCoke Energy, Inc. (NYSE: SXC) announced plans to acquire Phoenix Global, a privately held provider of mill services to steel ...

Reddit, Inc. filed a lawsuit earlier this month against Anthropic, PBC, accusing the artificial intelligence company of unauthorized use of Reddit’s content to train its AI models. The complaint, ...

As malls across America struggle for shoppers, DICK’S Sporting Goods, Inc. announced plans to acquire Foot Locker, Inc. for $2.5 billion. The merger agreement permits Foot Locker shareholders to elect ...

Alternative asset management firm TPG announced plans to acquire Sabre Corporation’s Hospitality Solutions business for $1.1 billion. The all-cash deal is projected to net Sabre $960 million, after ...

Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a ...

Amid President Trump’s recent high-profile efforts to punish or extract concessions from major law firms, a second front, much less publicized, has opened, with organizers of Project 2025 using the ...